Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence.
about
Pharmacotherapy for the management of achalasia: Current status, challenges and future directionsDysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study.Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled TrialPharmacokinetics and pharmacodynamics of incobotulinumtoxinA influencing the clinical efficacy in post-stroke spasticity.Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products.Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis: A Randomized Clinical Trial.Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.
P2860
Q26777632-885FE80E-45D3-44F5-A889-A3FCE7BD2D51Q35175351-42D3A4F6-9FF8-4EBE-B3F9-F36303037AB1Q35647787-6480F197-5B73-4143-B5F0-E4F797DD9544Q38735879-E1DD197A-AF4D-4745-B1EF-FB5F5216750BQ43185582-14B258D7-049C-443B-8477-471E12AE4C21Q47253498-B041A32D-88D1-4DF5-AF92-782213361F68Q47729274-10A7EFB7-3FBF-46E3-B522-3734151BD71B
P2860
Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Conversion ratio between Dyspo ...... verview of available evidence.
@en
type
label
Conversion ratio between Dyspo ...... verview of available evidence.
@en
prefLabel
Conversion ratio between Dyspo ...... verview of available evidence.
@en
P2093
P2860
P1476
Conversion ratio between Dyspo ...... verview of available evidence.
@en
P2093
Alberto Mazza
Domenico De Grandis
Roberta Ravenni
P2860
P2888
P304
P356
10.1007/S10072-013-1357-1
P577
2013-04-11T00:00:00Z